Nektar Therapeutics Inc. (0UNL)
Market Closed
24 Feb, 15:30
LSE 
$
68. 98
-2.76
-3.85%
$
- Market Cap
- P/E Ratio
- Div Yield
1,643 Volume
-0.72 Eps
$ 71.74
Previous Close Day Range
68.36 73.53
Year Range
68.36 73.53
Want to track 0UNL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
0UNL earnings report is expected in 13 days (10 Mar 2026)
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
0UNL Earnings Reports FAQ
What is the earnings per share (EPS) for 0UNL?
The current EPS is -0.72.
What is the company's earnings growth rate?
Nektar Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-03-10, based on the 0UNL's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nektar Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0UNL at this time, as Nektar Therapeutics Inc has no recent EPS data to calculate it.
